litlas
ログインアカウント作成

Geert D’Haens

1993–2026 年に発表

別表記
Geert D'Haens · Geert d’Haens
375
論文数
65,856
被引用数
124
h 指数
347
i10 指数

被引用数

Geert D’Haens の年別被引用数1990 年: 被引用 2 件1991 年: 被引用 2 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 6 件1997 年: 被引用 5 件1998 年: 被引用 10 件1999 年: 被引用 29 件2000 年: 被引用 44 件2001 年: 被引用 90 件2002 年: 被引用 152 件2003 年: 被引用 133 件2004 年: 被引用 160 件2005 年: 被引用 181 件2006 年: 被引用 178 件2007 年: 被引用 162 件2008 年: 被引用 216 件2009 年: 被引用 291 件2010 年: 被引用 372 件2011 年: 被引用 402 件2012 年: 被引用 405 件2013 年: 被引用 501 件2014 年: 被引用 542 件2015 年: 被引用 567 件2016 年: 被引用 548 件2017 年: 被引用 604 件2018 年: 被引用 668 件2019 年: 被引用 2,296 件2020 年: 被引用 2,483 件2021 年: 被引用 2,171 件2022 年: 被引用 1,988 件2023 年: 被引用 2,084 件2024 年: 被引用 3,113 件2025 年: 被引用 1,737 件2026 年: 被引用 37 件1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,782 件、この内訳の 19%イギリス: 引用元論文 1,522 件、この内訳の 7.6%中国: 引用元論文 1,399 件、この内訳の 7%イタリア: 引用元論文 1,336 件、この内訳の 6.7%カナダ: 引用元論文 1,223 件、この内訳の 6.1%フランス: 引用元論文 1,098 件、この内訳の 5.5%ドイツ: 引用元論文 1,005 件、この内訳の 5.1%オランダ: 引用元論文 864 件、この内訳の 4.3%ベルギー: 引用元論文 804 件、この内訳の 4%スペイン: 引用元論文 710 件、この内訳の 3.6%日本: 引用元論文 571 件、この内訳の 2.9%オーストラリア: 引用元論文 534 件、この内訳の 2.7%
0%19%その他 25.5%

機関

分野

  • Biochemistry, Genetics and Molecular Biology57.4%
  • Medicine31.7%
  • Immunology and Microbiology6.1%
  • Neuroscience1%
  • Nursing0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • その他2.3%

トピック

  • Inflammatory Bowel Disease20.1%
  • Microscopic Colitis7.4%
  • Gut microbiota and health4.1%
  • Rheumatoid Arthritis Research and Therapies3.5%
  • Autoimmune and Inflammatory Disorders3%
  • Biosimilars and Bioanalytical Methods2.3%
  • その他59.6%

共著者

全論文

検索で開く
  1. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Chinyu Su, Bruce E. Sands, Geert D’Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G. Feagan, Walter Reinisch, Wojciech Niezychowski, Gary S. Friedman, Nervin Lawendy, Dahong Yu, Deborah Woodworth, Arnab Mukherjee, Haiying Zhang, Paul J. Healey, Julián Panés - New England Journal of Medicine 2017 被引用: 1,727

  2. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

    著者: Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L. Pangan, Jesse Siffledeen, Susan Greenbloom, Xavier Hébuterne, Geert D’Haens, Hiroshi Nakase, Julián Panés, Peter Higgins, Pascal Juillerat, James O. Lindsay, Edward V. Loftus, William J. Sandborn, Walter Reinisch, Minhu Chen, Yuri Sánchez González, Bidan Huang, Wangang Xie, John Liu, Michael Weinreich, Remo Panaccione - The Lancet 2022 被引用: 597

  3. Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

    著者: Edward V. Loftus, Julián Panés, Ana P. Lacerda, Laurent Peyrin‐Biroulet, Geert D’Haens, Remo Panaccione, Walter Reinisch, Édouard Louis, Minhu Chen, Hiroshi Nakase, Jakob Begun, Brigid S. Boland, Charles D. Phillips, Mohamed‐Eslam F. Mohamed, Jianzhong Liu, Ziqian Geng, Tian Feng, Elena Dubcenco, Jean‐Frédéric Colombel - New England Journal of Medicine 2023 被引用: 427

  4. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

    著者: Marco Daperno, Geert D’Haens, Gert Van Assche, Filip Baert, P. Bulois, V. Maunoury, R. Sostegni, Rodolfo Rocca, A. Pera, Annemie Gevers, Jean-Yves Mary, Jean-Frédéric Colombel, Paul Rutgeerts - Gastrointestinal Endoscopy 2004 被引用: 1,774

  5. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    著者: William J. Sandborn, Séverine Vermeire, Laurent Peyrin‐Biroulet, Marla C. Dubinsky, Julián Panés, Andrés Yarur, Timothy E. Ritter, Filip Baert, Stefan Schreiber, Sheldon Sloan, Fabio Cataldi, Kevin Shan, Christopher J. Rabbat, Michael Chiorean, Douglas C. Wolf, Bruce E. Sands, Geert D’Haens, Silvio Danese, Martina Goetsch, Brian G. Feagan - The Lancet 2023 被引用: 333

  6. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

    著者: Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, Gerassimos J. Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D’Haens, Robert H. Diamond, Delma L. Broussard, Kezhen L. Tang, C. Janneke van der Woude, Paul Rutgeerts - New England Journal of Medicine 2010 被引用: 3,108

  7. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Brian G. Feagan, Geert D’Haens, Douglas C. Wolf, Igor Jovanović, Stephen B. Hanauer, Subrata Ghosh, AnnKatrin Petersen, Steven Y. Hua, Ji Hwan Lee, Lorna Charles, Denesh K. Chitkara, Keith Usiskin, Jean–Frédéric Colombel, Loren Laine, Silvio Danese - New England Journal of Medicine 2021 被引用: 532

  8. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    著者: Geert D’Haens, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Marc Ferrante - The Lancet 2022 被引用: 387

  9. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    著者: Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 被引用: 1,838

  10. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Geert D’Haens, Marla C. Dubinsky, Taku Kobayashi, Peter M. Irving, Stefanie Howaldt, Juris Pokrotnieks, Kathryn A. Krueger, Janelle Laskowski, Xingyuan Li, Trevor Lissoos, Joe Milata, Nathan Morris, Vipin Arora, Catherine Milch, William J. Sandborn, Bruce E. Sands - New England Journal of Medicine 2023 被引用: 317

  11. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

    著者: Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukáš, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Daniël W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Méndez, Joel Petersson, Kori Wallace, Anne Robinson, Roopal Thakkar, Geert D’Haens - The Lancet 2017 被引用: 912

  12. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    著者: Marc Ferrante, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Geert D’Haens - The Lancet 2022 被引用: 316

  13. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

    著者: Bram Verstockt, Azucena Salas, Bruce E. Sands, Clara Abraham, Haim Leibovitzh, Markus F. Neurath, Niels Vande Casteele, Silvio Danese, Geert D’Haens, Lars Eckmann, William A. Faubion, Brian G. Feagan, Vipul Jairath, Christopher Ma, Saurabh Mehandru, Julián Panés, Florian Rieder, William J. Sandborn, Mark S. Silverberg, Marisol Veny, Séverine Vermeire, Stefania Vetrano - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 231

  14. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

    著者: Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, J. Załuski, Chung-Rong Chang Chien, Anatoly Makhson, Geert D’Haens, Tamás Pintér, Robert Lim, G. Bodoky, Jae Kyung Roh, Gunnar Folprecht, Paul Ruff, Christopher Stroh, Sabine Tejpar, Michael Schlichting, Johannes Nippgen, Philippe Rougier - New England Journal of Medicine 2009 被引用: 3,868

  15. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

    著者: Noortje Rossen, Susana Fuentes, Mirjam J. van der Spek, Jan G.P. Tijssen, Jorn Hartman, Ann Duflou, Mark Löwenberg, Gijs R. van den Brink, Elisabeth M. H. Mathus-Vliegen, Willem M. de Vos, Erwin G. Zoetendal, Geert D’Haens, Cyriel Y. Ponsioen - Gastroenterology 2015 被引用: 931

  16. Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

    著者: William J. Sandborn, Brian G. Feagan, Edward V. Loftus, Laurent Peyrin‐Biroulet, Gert Van Assche, Geert D’Haens, Stefan Schreiber, Jean‐Frédéric Colombel, James D. Lewis, Subrata Ghosh, Alessandro Armuzzi, Ellen Scherl, Hans Herfarth, L.M. Vitale, Mohamed‐Eslam F. Mohamed, Ahmed A. Othman, Qian Zhou, Bidan Huang, Roopal Thakkar, Aileen L. Pangan, Ana P. Lacerda, Julián Panés - Gastroenterology 2020 被引用: 317

  17. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

    著者: Nurulamin M Noor, James Lee, Simon Bond, Francis Dowling, Biljana Brezina, Kamal Patel, Tariq Ahmad, Paul Banim, James Berrill, Rachel Cooney, Juan De La Revilla Negro, Shanika de Silva, Shahida Din, Dharmaraj Durai, J Gordon, Peter M. Irving, Matthew W. Johnson, Alexandra Kent, Klaartje Kok, Gordon W. Moran, Craig Mowat, Pritash Patel, C Probert, Tim Raine, Rebecca Saich, Abigail Seward, Dan Sharpstone, Melissa Smith, Sreedhar Subramanian, Sara Upponi, Alan A. Wiles, Horace R. Williams, Gijs R. van den Brink, Séverine Vermeire, Vipul Jairath, Geert D’Haens, Eoin McKinney, Paul Lyons, James O. Lindsay, Nicholas A. Kennedy, Kenneth G. C. Smith, Miles Parkes, Nurulamin M Noor, James Lee, Simon Bond, Francis Dowling, Biljana Brezina, Kamal Patel, Tariq Ahmad, Paul Banim, James Berrill, Rachel Cooney, Juan De La Revilla Negro, Shanika de Silva, Shahida Din, Dharmaraj Durai, J Gordon, Peter M. Irving, Matthew W. Johnson, Alexandra Kent, Klaartje Kok, Gordon W. Moran, Craig Mowat, Pritash Patel, C Probert, Tim Raine, Rebecca Saich, Abigail Seward, Dan Sharpstone, Melissa Smith, Sreedhar Subramanian, Sara Upponi, Alan A. Wiles, Horace R. Williams, Gijs van Den Brink, Séverine Vermeire, Vipul Jairath, Geert D’Haens, Eoin McKinney, Paul Lyons, James O. Lindsay, Nicholas A. Kennedy, Kenneth G. C. Smith, Miles Parkes, Clare Allcock, Suhaylah Bhatti, Jonathan Blackwell, Robert Boulton-Jones, Matthew Brookes, Rhys O. Butcher, Jeffrey Butterworth, Karlena Champion, Rakesh Chaudhary, Andy Cole, Lauranne Derikx, Anjan Dhar, Mary Flowerdew, Rishi Goel, Ailsa Hart, R Hughes ほか 17 名 - ˜The œLancet. Gastroenterology & hepatology 2024 被引用: 281

  18. Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

    著者: William J. Sandborn, Geert D’Haens, Walter Reinisch, Julián Panés, Daphne Chan, Susana Gonzalez, Kathleen Weisel, Matthew Germinaro, Mary Ellen Frustaci, Zijiang Yang, Omoniyi J. Adedokun, Chenglong Han, Remo Panaccione, Tadakazu Hisamatsu, Silvio Danese, David T. Rubin, Bruce E. Sands, Anita Afzali, Jane M. Andrews, Brian G. Feagan - Gastroenterology 2022 被引用: 198

  19. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling

    著者: Pim J. Koelink, Felicia M. Bloemendaal, Bofeng Li, Liset Westera, Esther Vogels, Manon van Roest, Anouk K. Gloudemans, Angélique B. van ’t Wout, Hannelie Korf, Séverine Vermeire, Anje A. te Velde, Cyriel Y. Ponsioen, Geert D’Haens, J. Sjef Verbeek, Terrence L. Geiger, Manon E. Wildenberg, Gijs R. van den Brink - Gut 2019 被引用: 225

  20. Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

    著者: William J. Sandborn, Gert Van Assche, Walter Reinisch, Jean‐Frédéric Colombel, Geert D’Haens, Douglas C. Wolf, Martina Kron, Mary Beth Tighe, Andreas Lazar, Roopal Thakkar - Gastroenterology 2011 被引用: 1,258

  21. Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis

    著者: William J. Sandborn, Filip Baert, Silvio Danese, Željko Krznarić, Taku Kobayashi, Xiaopan Yao, Jingjing Chen, Maria Rosario, Siddharth Bhatia, Krisztina Kisfalvi, Geert D’Haens, Séverine Vermeire - Gastroenterology 2019 被引用: 317

  22. Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial

    著者: Séverine Vermeire, Geert D’Haens, Filip Baert, Silvio Danese, Taku Kobayashi, Edward V. Loftus, Siddharth Bhatia, Christian Agboton, Maria Rosario, Chunlin Chen, Wenwen Zhang, Krisztina Kisfalvi, William J. Sandborn - Journal of Crohn s and Colitis 2021 被引用: 170

  23. Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease

    著者: Bruce E. Sands, Laurent Peyrin‐Biroulet, Jarosław Kierkuś, Peter Higgins, Monika Fischer, Vipul Jairath, Fumihito Hirai, Geert D’Haens, Ruth M. Belin, Debra L. Miller, Elisa Gomez‐Valderas, April N. Naegeli, Jay Tuttle, Paul F. Pollack, William J. Sandborn - Gastroenterology 2021 被引用: 149

  24. Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

    著者: Bruce E. Sands, Brian G. Feagan, Paul Rutgeerts, Jean‐Frédéric Colombel, William J. Sandborn, Richmond Sy, Geert D’Haens, Shomron Ben‐Horin, Jing Xu, Maria Rosario, Irving H. Fox, Asit Parikh, Catherine Milch, Stephen B. Hanauer - Gastroenterology 2014 被引用: 705